glutamine and Carcinoma, Basal Cell, Pigmented

glutamine has been researched along with Carcinoma, Basal Cell, Pigmented in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chen, H; Hsu, R; Lee, CN; Wong, TW	1
Alaibac, M; Frigo, AC; Michelotto, A; Piaserico, S	1
Bermejo, JL; Gurzau, E; Hemminki, K; Koppova, K; Kumar, R; Rudnai, P; Scherer, D	1
Dybdahl, M; Frentz, G; Nexø, BA; Vogel, U; Wallin, H	1

Reviews

1 review(s) available for glutamine and Carcinoma, Basal Cell, Pigmented

Article	Year
Daylight Photodynamic Therapy: An Update. Molecules (Basel, Switzerland), 2020, Nov-08, Volume: 25, Issue:21 Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Cheilitis; Europe; Glucose; Glutamine; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Radiation Exposure; Sunlight; Time Factors; Xeroderma Pigmentosum	2020

Article

Year

Daylight Photodynamic Therapy: An Update.

Molecules (Basel, Switzerland), 2020, Nov-08, Volume: 25, Issue:21

Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Cheilitis; Europe; Glucose; Glutamine; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Radiation Exposure; Sunlight; Time Factors; Xeroderma Pigmentosum

2020

Other Studies

3 other study(ies) available for glutamine and Carcinoma, Basal Cell, Pigmented

Article	Year
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study. Pharmacogenomics, 2015, Volume: 16, Issue:17 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Imiquimod; Leucine; Male; Pilot Projects; Polymorphism, Single Nucleotide; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome	2015
MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. International journal of cancer, 2008, Apr-15, Volume: 122, Issue:8 Topics: Adult; Aged; Arginine; Carcinoma, Basal Cell; Case-Control Studies; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Hungary; Male; Methionine; Middle Aged; Polymorphism, Genetic; Receptor, Melanocortin, Type 1; Risk Factors; Romania; Sequence Analysis, DNA; Skin Neoplasms; Slovakia; Threonine	2008
Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:1 Topics: Adenine; Adult; Age Factors; Age of Onset; Alleles; Carcinoma, Basal Cell; Confidence Intervals; Cytosine; DNA Helicases; DNA Repair; DNA-Binding Proteins; Exons; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glutamine; Humans; Lysine; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Proteins; Psoriasis; Risk Factors; Transcription Factors; Transcription, Genetic; Xeroderma Pigmentosum Group D Protein	1999